CMPI.org

In the News

Peter Pitts discusses new GOP Healthcare Plan

03/09/2017 12:00 AM | i24NEWS

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

03/08/2017 12:00 AM | NY1 News Capital Tonight

U.N.'s errant prescription for drug access

02/27/2017 12:00 AM | Pittsburgh Tribune

How Other Countries Freeload on U.S. Drug Research

02/21/2017 12:00 AM | Wall Street Journal

Reduce drug prices by eliminating PBM rebates

02/15/2017 12:00 AM | The Hill

The Privacy Delusions Of Genetic Testing

02/15/2017 12:00 AM | Forbes

Controlling Cost Through Value

02/10/2017 12:00 AM | Morning Consult

President Trump misunderstands what government drug price negotiations entail

02/01/2017 12:00 AM | Washington Examiner

Keep the feds out of drug pricing

12/18/2016 12:00 AM | USA Today

There is a Sure Cure, But It's Not Covered by Your Health Insurance Plan

09/17/2016 12:00 AM | Newsweek

Pitts on EpiPen outrage: 'Perfect storm of stupidity'

08/24/2016 12:00 AM | CNBC

Superbug Nightmare: The Danger of Taking Too Many Antibiotics

08/23/2016 12:00 AM | CBN News

On Assignment: Bitter Pill

06/17/2016 12:00 AM | NBC Dateline

360 Degree Global Trade and the Urgent Need for the Trans-Pacific Partnership

05/11/2016 12:00 AM | CMPI

FDA takes step to improve generic drug competition

03/15/2016 12:00 AM | Marketplace

Single-payer health care unworkable, too costly

03/07/2016 12:00 AM | Philadelphia Inquirer

Congress must protect vital drug patents from Wall Street attacks

01/14/2016 12:00 AM | Morrow County Sentinel

James P. Pinkerton, Cures Strategy founder, Fox News Analyst, and Reagan White House alumni, Joins CMPI

01/05/2016 12:00 AM | CMPI

Obamacare's slippery slope to single-payer system

12/03/2015 12:00 AM | CNBC

States copying market-based Medicare plan

12/03/2015 12:00 AM | Philly.com

Previous
1
...
8
9
10
11
12
Next

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

CMPI
02/03/2026 12:00 AM

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more

Read all News